KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 113 filers reported holding KRYSTAL BIOTECH INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,554 | -1.2% | 185,809 | 0.0% | 0.29% | +4.3% |
Q2 2023 | $21,814 | +20.7% | 185,809 | -17.7% | 0.28% | +13.7% |
Q1 2023 | $18,078 | +1.1% | 225,809 | 0.0% | 0.25% | +4.6% |
Q4 2022 | $17,889 | -99.9% | 225,809 | 0.0% | 0.24% | +9.2% |
Q3 2022 | $15,739,000 | +6.2% | 225,809 | 0.0% | 0.22% | +16.7% |
Q2 2022 | $14,827,000 | -1.3% | 225,809 | 0.0% | 0.19% | +13.4% |
Q1 2022 | $15,025,000 | +15.6% | 225,809 | +21.5% | 0.16% | +33.3% |
Q4 2021 | $12,997,000 | +34.0% | 185,809 | 0.0% | 0.12% | +23.0% |
Q3 2021 | $9,701,000 | -23.2% | 185,809 | 0.0% | 0.10% | -23.1% |
Q2 2021 | $12,635,000 | -11.7% | 185,809 | 0.0% | 0.13% | -7.1% |
Q1 2021 | $14,315,000 | +28.4% | 185,809 | 0.0% | 0.14% | +25.0% |
Q4 2020 | $11,149,000 | +39.4% | 185,809 | 0.0% | 0.11% | +24.4% |
Q3 2020 | $7,999,000 | +42.2% | 185,809 | +36.8% | 0.09% | +36.4% |
Q2 2020 | $5,625,000 | -4.2% | 135,809 | 0.0% | 0.07% | -19.5% |
Q1 2020 | $5,872,000 | – | 135,809 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
Artal Group S.A. | 412,082 | $32,991 | 1.96% |
First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |